S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Birincioglu, Mustafa ^a   Yang, Xi Ming ^a   Critz, Stuart D ^a   Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

5 hydroxydecanoate; Adenosine 5' triphosphate sensitive potassium channel; Anisomycin; Diazoxide; HMR 1883

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; ANISOMYCIN; CLAMIKALANT; DIAZOXIDE; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; DATA ANALYSIS; ELECTRIC POTENTIAL; ELECTROCARDIOGRAM; ELECTROMYOGRAM; HEART INFARCTION; HEART INFARCTION PREVENTION; PRIORITY JOURNAL; RELIABILITY; SARCOLEMMA; ST SEGMENT; STRESS STRAIN RELATIONSHIP;

EID: 0033383151     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.6.h2435     Document Type: Article

References (26)

1. ATP channels and actin cytoskeleton. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H1361-H1368, 1999.
2. Baines, C. P., L. Wang, M. V. Cohen, and J. M. Downey. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J. Mol. Cell. Cardiol. 30: 383-392, 1998.
3. Birnbaum, Y., S. L. Hale, and R. A. Kloner. Progressive decrease in the ST segment elevation during ischemic preconditioning: is it related to recruitment of collateral vessels? J. Mol. Cell. Cardiol. 28: 1493-1499, 1996.
4. Cohen, M. V., X.-M. Yang, and J. M. Downey. Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon. Basic Res. Cardiol. 92: 426-434, 1997.
5. Das, D. K., N. Maulik, T. Yoshida, R. M. Engelman, and Y.-L. Zu. Preconditioning potentiates molecular signaling for myocardial adaptation to ischemia. Ann. NY Acad. Sci. 793: 191-209, 1996.
6. Deutsch, E., M. Berger, W. G. Kussmaul, J. W. Hirshfeld, Jr., H. C. Herrmann, and W. K. Laskey. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 82: 2044-2051, 1990.
7. + channels: possible mechanism of cardioprotection. Circ. Res. 81: 1072-1082, 1997.
8. ATP channel as a receptor for potassium channel openers. J. Biol. Chem. 271: 8796-8799, 1996.
9. Gögelein, H., J. Hartung, H. C. Englert, and B. A. Schölkens. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. I. Effects on cardiomyocytes, coronary flow and pancreatic β-cells. J. Pharmacol. Exp. Ther. 286:1453-1464, 1998.
10. Gross, G. J., and J. A. Auchampach. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
11. 1-receptors. Circulation 86: 1310-1316, 1992.
12. Htun, P., Y. Maeno, and W. Schaper. Stress-activated protein kinases induce cardioprotection (Abstract). J. Mol. Cell. Cardiol. 29:A65, 1997.
13. Kerensky, R. A., M. A. Kutcher, G. A. Braden, R. J. Applegate, G. A. Solis, and W. C. Little. The effects of intracoronary adenosine on preconditioning during coronary angioplasty. Clin. Cardiol. 18: 91-96, 1995.
14. Liu, Y., T. Sato, B. O'Rourke, and E. Marban. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469, 1998.
15. Ludbrook, J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res. 28: 303-311, 1994.
16. Maulik, N., M. Watanabe, Y.-L. Zu, C.-K. Huang, G. A. Cordis, J. A. Schley, and D. K. Das. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396: 233-237, 1996.
17. McCullough, J. R., D. E. Normandin, M. L. Conder, P. G. Sleph, S. Dzwonczyk, and G. J. Grover. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ. Res. 69: 949-958, 1991.
18. National Research Council. Guide for the Care and Use of Laboratory Animals (7th ed.). Washington, DC: Natl. Acad. Press, 1996.
19. Shattock, M. J., C. S. Lawson, D. J. Hearse, and J. M. Downey. Electrophysiological characteristics of repetitive ischemic preconditioning in the pig heart. J. Mol. Cell. Cardiol. 28: 1339-1347, 1996.
20. 1-selective adenosine analogues protects the heart against infarction. Circulation 85: 659-665, 1992.
21. Tomai, F., F. Crea, L. Chiariello, and P. A. Gioffrè. Ischemic preconditioning in humans: models, mediators and clinical relevance. Circulation 100: 559-563, 1999.
22. + channel blocker. Circulation 90: 700-705, 1994.
23. 1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur. Heart J. 17: 846-853, 1996.
24. Toombs, C. F., T. L. Moore, and R. J. Shebuski. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc. Res. 27: 617-622, 1993.
25. Weinbrenner, C., G.-S. Liu, M. V. Cohen, and J. M. Downey. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J. Mol. Cell. Cardiol. 29: 2383-2391, 1997.
26. Zanke, B. W., E. A. Rubie, E. Winnett, J. Chan, S. Randall, M. Parsons, K. Boudreau, M. McInnis, M. Yan, D. J. Templeton, and J. R. Woodgett. Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. J. Biol. Chem. 271: 29876-29881, 1996.